Clinical Trials Logo
  1. Home
  2. Lumbar Disc Disease
  3. NCT01941563
  4. Details
NCT01941563 Clinical Trial

A Study of SI-6603 in Patients With Lumbar Disc Herniation

Lumbar Disc Disease Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01941563
Other study ID # 6603/1131
Secondary ID 6603/1131
Status Completed
Phase Phase 3
First received
Last updated
Start date September 2013
Est. completion date August 2017

Study information
Verified date March 2023
Source Seikagaku Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.

Recruitment information / eligibility
Status Completed
Enrollment 385
Est. completion date August 2017
Est. primary completion date November 2015
Accepts healthy volunteers No
Gender All
Age group 30 Years to 70 Years
Eligibility Inclusion Criteria: - Patients with lumbar disc herniation (L4-L5 or L5-S1) as assessed by MRI and clinical symptoms corresponding to position of the impaired nerve root. - Patients assessed as positive in the SLR test. - Patients with sciatica in either leg. - Patients with no improvement from conservative treatment Exclusion Criteria: - Patients who have 2 or more lumbar disc herniations as assessed by MRI. - Patients in whom a rupture into the posterior longitudinal ligament is identified by MRI. - Patients who have received spinal injection, epidural injection, nerve block within 3 weeks prior to the time of informed consent. - Patients who have undergone lumbar operation, or lumbar percutaneous nucleotomy or lumbar intradiscal therapies

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Condoliase
1.25U, intradiscal injection, one time
• placebo

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Seikagaku Corporation

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Leg pain Assessed by Visual Analog Scale (VAS) 13 weeks
Secondary Responder rate evaluation Assessed by leg pain (VAS), Oswestry Disability Index disability questionnaire, neurologic status (motor, sensory, reflexes), and no treatment failure 13 weeks
See also
  Status Clinical Trial Phase
Completed NCT04061759 - Physiotherapy in Lumbar Disc Pathologies N/A
Recruiting NCT04727385 - Intervertebral DXM Gel Injection in Adults With Painful Lumbar Degenerative Disc Disease N/A
Completed NCT04587401 - The Effects of Anesthesia on Cerebral Perfusion in Patients With High Blood Pressure N/A
Not yet recruiting NCT06034041 - The Effect of Mediclore as an Anti-adhesion Agent and Safety in Full-endoscopic Spine Surgery: a Preliminary Study Phase 4
Recruiting NCT04134975 - Evaluation of the Contribution of Intraoperative Scans Coupled With the Navigation for the Precision of the Positioning of the Pedicle Screws During a Lumbar Spine Surgery: a Prospective Randomised Study N/A
Recruiting NCT05146583 - Injection of Autologous Bone Marrow Aspirate in Patients With Degenerative Disc Disease.
Recruiting NCT04641039 - Postoperative Scar in the Control Excess of Mobility Induced by Annulus Removal on Inserting a Lumbar Disc Prosthesis N/A
Completed NCT04301232 - Fast-Track Eligibility and Hospital Discharge for Outpatient Lumbar Discectomy
Recruiting NCT06154005 - OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion Phase 1/Phase 2
Completed NCT03977961 - The Six-Minute Walking Test (6MWT) as a Measure of Functional Impairment in Lumbar Degenerate Disc Disease.
Enrolling by invitation NCT05444751 - GA + ESP vs. SA + ESP in Lumbar Decompression Surgeries Phase 3
Completed NCT02700451 - Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes N/A
Completed NCT02421601 - A Study of SI-6603 in Patients With Lumbar Disc Herniation Phase 3
Active, not recruiting NCT03733626 - Clinical Outcomes Associated With the Use of ViviGen® for the Treatment of Lumbar Degenerative Disc Disease N/A
Recruiting NCT04042844 - A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD) Phase 2
Completed NCT05345249 - Erector Spinae Plane Block as Pain Management After Lumbar Fusion Surgery Phase 4
Active, not recruiting NCT03060434 - Pentoxifylline and Lumbar Radiculopathy Phase 4
Withdrawn NCT02852187 - Single Center Study Comparing MOBIS II ST vs MOBIS PEEK N/A
Completed NCT04062942 - The Six-Minute Walking Test (6WT) and Timed-Up-and-Go (TUG) Test as Measures of Objective Functional Impairment in Patients Undergoing Interlaminar or Transforaminal Epidural Steroid Injection for Lumbar Degenerative Disc Disease (DDD)
Recruiting NCT03745040 - Liposomal Bupivacaine in One-level Instrumented Posterior Spinal Fusion Phase 4